Solid Tumors

Latest News

FDA Updates: Assays Used in Cancer Care Get Green Light
FDA Updates: Assays Used in Cancer Care Get Green Light

August 9th 2020

Adaptive Biotechnologies’ clonoSEQ gets third approval; FDA also acts on first at-home treatment for spinal muscular atrophy.

Keytruda Approved for Early Treatment of Colorectal Cancer in Patients With Genetic Mutations
Keytruda Approved for Early Treatment of Colorectal Cancer in Patients With Genetic Mutations

June 30th 2020

Rising drug costs
Payers Should Take Action on Rising NSCLC Costs

November 29th 2019

Cancer patient
Chemotherapy Remains Significant for Cancer Treatment

November 29th 2019

TCells Attacking
Personalized Treatments Could Increase Value of Cancer Care

November 25th 2019

Latest CME Events & Activities

Expanding the Armamentarium of Actionable Mutations in NSCLC: Uncovering the Potential of CEACAM5 as a Therapeutic Target

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

Pathology Implications for CEACAM5 as a Therapeutic Target in Advanced NSCLC

View More

Medical Crossfire®: What Are Effective Strategies for Onco-Nurses to Improve Outcomes in Patients with Small Cell Lung Cancer?

View More

Virtual Show Me the Data™: How HER2, HER3, and TROP2 Targeted Strategies Will Impact Evolving Paradigms in NSCLC

View More

42nd Annual CFS®: Innovative Cancer Therapy for Tomorrow®

November 13-15, 2024

Register Now!

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

How CEACAM5 Expression Can Be Measured and Leveraged in NSCLC Care: Current Developments & Future Therapeutic Opportunities

View More

Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!

View More

22nd Annual Winter Lung Cancer Conference®

January 31, 2025 - February 2, 2025

Register Now!

Dialogues With the Surgeon on Integration of Systemic Therapies in Perioperative Settings for NSCLC: Looking at EGFR, ALK, IO, and Beyond…

View More

More News

© 2024 MJH Life Sciences

All rights reserved.